W.G. Shaheen & Associates Dba Whitney & CO Vertex Pharmaceuticals Inc Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$910 Million
Q4 2024

A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 43,246 shares of VRTX stock, worth $19.8 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

43,246

Previous 43,406 0.37%

Holding current value

$19.8 Million

Previous $20.2 Million 13.73%

% of portfolio

1.91%

Previous 2.21%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$396.64 - $516.74 $63,462 - $82,678	-160 Reduced 0.37%	43,246 $17.4 Million
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $3.56 Million - $3.92 Million	-7,748 Reduced 15.15%	43,406 $20.2 Million
Q2 2024 Jul 30, 2024	BUY	$392.81 - $485.53 $234,114 - $289,375	596 Added 1.18%	51,154 $24 Million
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $216,075 - $236,422	530 Added 1.06%	50,558 $21.1 Million
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $31,899 - $38,193	93 Added 0.19%	50,028 $20.4 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $136,962 - $146,796	405 Added 0.82%	49,935 $17.4 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $1.66 Million - $1.86 Million	-5,272 Reduced 9.62%	49,530 $17.4 Million
Q1 2023 May 03, 2023	BUY	$283.23 - $323.1 $549,466 - $626,814	1,940 Added 3.67%	54,802 $17.3 Million
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $183,743 - $206,711	643 Added 1.23%	52,862 $15.3 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $105,150 - $117,323	384 Added 0.74%	52,219 $15.1 Million
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $73,072 - $90,983	311 Added 0.6%	51,835 $14.6 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $307,552 - $362,487	1,389 Added 2.77%	51,524 $13.4 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $129,748 - $163,788	733 Added 1.48%	50,135 $11 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $636,497 - $712,291	3,509 Added 7.65%	49,402 $8.96 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $8.6 Million - $10.1 Million	45,893 New	45,893 $9.25 Million

Others Institutions Holding VRTX

# of Institutions

1,745

Shares Held

227M

Call Options Held

1.53M

Put Options Held

1.4M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $118B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account

W.G. Shaheen & Associates Dba Whitney & CO Vertex Pharmaceuticals Inc Transaction History